Press-release for stocks publishing date 2022 - 03

Prices are updated after-hours

publishing date : 2022 - 03 - 08 source : Www.biospace.com

save search

Kura Oncology Announces Multiple Abstracts Accepted for Presentation at AACR Annual Meeting– Presentations to highlight significant opportunities targeting farnesyl transferase inhibition –
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
KURA | $17.66 -1.83% -1.87% 1.7M

Health Technology

| 11.05% | O: 0.43% H: 0.0% C: 0.0%
ces presentation

Xencor to Present Preclinical Data from XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
XNCR | $18.98 -0.47% -0.47% 470K

Health Technology

| -32.59% | O: 0.14% H: 0.0% C: 0.0%
xmab america program research preclinical cancer pre-clinical

Alpine Immune Sciences Announces Oral Presentation at the 2022 AACR Annual Meeting
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
ALPN | $64.45 -0.02% -0.02% 2.5M

Health Technology

| 823.35% | O: 2.94% H: 0.0% C: 0.0%
presentation

Repare Therapeutics to Present Comprehensive Phase 1 Monotherapy Data From the Phase 1/2 TRESR RP-3500 Clinical Trial and SNiPDx Panel at the 2022 AACR Annual Meeting
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
RPTX 4 | $3.025 -5.76% -6.12% 140K

Health Technology

| -77.63% | O: -2.02% H: 0.0% C: 0.0%
rp-3500 500 trial therapeutics phase 1 therapy phase 2 phase 3

Exscientia to Highlight Precision Medicine Platform and Pipeline Data at the American Association of Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
EXAI | $4.35 0.69% 0.69% 330K

| -63.86% | O: 0.0% H: 14.63% C: 12.76%
america research cancer platform

Yield10 Bioscience Announces Recent Advances in the Development of Camelina as a Production Platform for PHA Bioplastic
Published: 2022-03-08 (Crawled : 21:00) - biospace.com/
YTEN | $0.2785 -1.79% 280K

Health Technology

| -94.91% | O: 0.36% H: 4.11% C: -21.56%
bioscience platform

Mustang Bio Completes a $75 Million Debt Financing with Runway Growth Capital
Published: 2022-03-08 (Crawled : 21:00) - biospace.com/
RWAY | $12.605 0.2% 0.2% 240K

| 1.04% | O: 0.0% H: 0.0% C: -1.93%
MBIO | $0.3819 -0.55% -1.05% 200K

Health Technology

| -49.67% | O: 4.56% H: 12.11% C: -2.17%
FBIO | $1.81 2.26% 2.21% 440K

Health Technology

| 34.35% | O: 0.76% H: 2.27% C: 0.0%
growth

Biocept Appoints Philippe Marchand as Chief Operating Officer
Published: 2022-03-08 (Crawled : 21:00) - biospace.com/
BIOC | $0.4349 -10.32% 750K

Health Services

| -78.68% | O: 0.49% H: 0.0% C: -2.93%

SCYNEXIS Named to Fast Company’s 2022 Top 50 List of the World’s Most Innovative Companies
Published: 2022-03-08 (Crawled : 21:00) - biospace.com/
SCYX | $1.47 3.52% 3.4% 80K

Health Technology

| -61.73% | O: -1.08% H: 3.84% C: -3.0%

Ambrx Biopharma Inc. to Present at Oppenheimer’s 32nd Annual Healthcare Conference
Published: 2022-03-08 (Crawled : 21:00) - biospace.com/
AMAM 4 | $28.0 0.0% 1.4M

Professional, Scientific, and T...

| 511.35% | O: 0.33% H: 5.33% C: 2.07%
health biopharma thc conference

Panbela Schedules Conference Call on March 24, 2022, to Report 2021 Fourth Quarter Financial Results
Published: 2022-03-08 (Crawled : 21:00) - biospace.com/
PBLA | $1.15 -6.31% 360K

Professional, Scientific, and T...

| -71.58% | O: 1.64% H: 2.15% C: 0.54%
financial results conference report results

J&J Faces Scrutiny over Revelation of Involvement in Controversial Experiment
Published: 2022-03-08 (Crawled : 18:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M

Health Technology

| -14.0% | O: 1.89% H: 0.0% C: 0.0%
ces

OccamzRazor announces closing of $6.1M financing round to launch their AI-enabled discovery pipeline and advance preclinical development in Parkinson's.
Published: 2022-03-08 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M

Health Technology

| -14.0% | O: 1.89% H: 0.0% C: 0.0%
parkinson preclinical pre-clinical

Enzo Biochem to Report Second Quarter 2022 Financial Results and Business Update on Monday, March 14th
Published: 2022-03-08 (Crawled : 17:00) - biospace.com/
ENZ | $1.13 -1.74% 0.0% 200K

Health Technology

| -62.9% | O: 0.0% H: 4.19% C: 0.0%
day financial results report results

Annovis Bio Announces Presentation at International Conference on Alzheimer's & Parkinson's Diseases 2022
Published: 2022-03-08 (Crawled : 17:00) - biospace.com/
ANVS | $9.85 9.57% 0.96% 240K

Health Technology

| -14.86% | O: 1.35% H: 12.25% C: 4.17%
alzheimer parkinson conference presentation disease alzheimer’s alzheimer's

TC BioPharm Announces Positive Phase 1b/2a Data in Late-Stage Acute Myeloid Leukemia Patients Treated with Allogeneic Gamma Delta T Cells
Published: 2022-03-08 (Crawled : 17:00) - biospace.com/
TCBP | $1.45 7.41% 6.9% 170K

| -97.13% | O: 8.36% H: 12.75% C: -5.38%
myeloid leukemia pos phase 1b leukemia cel phase 1 positive t-cell acute myeloid leukemia phase 2b

Revelation Biosciences Inc. to Present at the 34th Annual Roth Conference
Published: 2022-03-08 (Crawled : 16:00) - biospace.com/
REVB | $2.15 10.75% 93K

| 130.49% | O: -4.59% H: 11.24% C: 3.91%
conference bioscience

AXIM Biotech Develops Rapid Quantitative Tear Test for MMP-9, An Inflammatory Biomarker of Dry Eye Disease
Published: 2022-03-08 (Crawled : 16:00) - biospace.com/
AXIM | $0.0155 -6.67% 75K

Manufacturing

| -91.31% | O: 5.57% H: 0.0% C: -12.22%
dry eye eye eye disease disease test biotech axim iot biomarkers

New Funding Initiatives Abound to Nurture Biotech Startups
Published: 2022-03-08 (Crawled : 16:00) - biospace.com/
BNPQF | News | $68.558 -13.4% 400

Finance

| 41.35% | O: 7.3% H: 4.67% C: 4.67%
BNPQY | News | $34.25 -2.68% 180K

Finance and Insurance

| 39.67% | O: 8.03% H: 2.96% C: -0.87%
MC | News | $50.97 -0.57% 0.0% 370K

Finance

| 13.81% | O: -0.84% H: 2.8% C: -0.56%
fun star funding biotech iot

Going All In on mRNA, Sanofi Breaks Ground on New Vaccine Site
Published: 2022-03-08 (Crawled : 15:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology